Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma-Reference-Cited by-同舟云学术

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Published:2021-05 Issue:5 Volume:39 Page:649-661.e5
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Bi Kevin,He Meng Xiao,Bakouny Ziad^ORCID,Kanodia Abhay,Napolitano Sara,Wu Jingyi^ORCID,Grimaldi Grace,Braun David A.^ORCID,Cuoco Michael S.^ORCID,Mayorga Angie,DelloStritto Laura^ORCID,Bouchard Gabrielle,Steinharter John,Tewari Alok K.,Vokes Natalie I.,Shannon Erin,Sun Maxine,Park Jihye,Chang Steven L.,McGregor Bradley A.^ORCID,Haq Rizwan^ORCID,Denize Thomas^ORCID,Signoretti Sabina^ORCID,Guerriero Jennifer L.^ORCID,Vigneau Sébastien,Rozenblatt-Rosen Orit,Rotem Asaf^ORCID,Regev Aviv,Choueiri Toni K.^ORCID,Van Allen Eliezer M.^ORCID

Funder

NCI Cancer Moonshot

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference64 articles.

1. IFN- γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer;Abiko;Br. J. Cancer,2015

2. CD24 signalling through macrophage Siglec-10 is a new target for cancer immunotherapy;Barkal;Nature,2019

3. In vivo molecular dissection of the effects of HIV-1 in active Tuberculosis;Bell;PLoS Pathog.,2016

4. Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression;Bellucci;OncoImmunology,2015

5. Controlling the false discovery rate: a practical and powerful approach to multiple testing;Benjamini;J. R. Stat. Soc. B,1995

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune landscape of renal cell carcinoma with metastasis to the pancreas;Urologic Oncology: Seminars and Original Investigations;2024-11

2. Immune Phenotype-Genotype Associations in Primary Clear Cell Renal Cell Carcinoma and Matched Metastatic Tissue;Modern Pathology;2024-10

3. The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy;European Journal of Immunology;2024-09-12

4. TUBA1C orchestrates the immunosuppressive tumor microenvironment and resistance to immune checkpoint blockade in clear cell renal cell carcinoma;Frontiers in Immunology;2024-09-05

5. Integrative analysis of bulk and single‐cell RNA sequencing reveals sphingolipid metabolism and immune landscape in clear cell renal cell carcinoma;Environmental Toxicology;2024-09-04